These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15034829)

  • 1. Intranasal influenza vaccine in a working population.
    Sendi P; Locher R; Bucheli B; Battegay M
    Clin Infect Dis; 2004 Apr; 38(7):974-80. PubMed ID: 15034829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of vaccination habit and vaccine choice on influenza vaccination among healthy working adults.
    Lin CJ; Nowalk MP; Toback SL; Rousculp MD; Raymund M; Ambrose CS; Zimmerman RK
    Vaccine; 2010 Nov; 28(48):7706-12. PubMed ID: 20638452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving influenza vaccination rates in the workplace: a randomized trial.
    Nowalk MP; Lin CJ; Toback SL; Rousculp MD; Eby C; Raymund M; Zimmerman RK
    Am J Prev Med; 2010 Mar; 38(3):237-46. PubMed ID: 20036102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events associated with intranasal influenza vaccine in the United States.
    Vasu N; Ghaffari G; Craig ET; Craig TJ
    Ther Adv Respir Dis; 2008 Aug; 2(4):193-8. PubMed ID: 19124371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age.
    Vesikari T; Karvonen A; Smith HM; Dunning A; Razmpour A; Saville MK; Gruber WC; Forrest BD
    Pediatrics; 2008 Mar; 121(3):e568-73. PubMed ID: 18299305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccine adverse event and effect on acceptability in pediatric residents.
    Kara A; Devrim I; Celik T; Akca T; Tezer H; Simsek OP; Kutluk T; Kale G; Secmeer G
    Jpn J Infect Dis; 2007 Nov; 60(6):387-8. PubMed ID: 18032840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live attenuated influenza vaccine in children.
    Ambrose CS; Walker RE; Connor EM
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of adverse events after influenza vaccination in hospital personnel.
    Scheifele DW; Bjornson G; Johnston J
    CMAJ; 1990 Jan; 142(2):127-30. PubMed ID: 2295029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects.
    Treanor J; Nolan C; O'Brien D; Burt D; Lowell G; Linden J; Fries L
    Vaccine; 2006 Jan; 24(3):254-62. PubMed ID: 16129526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccination coverage rates in Germany a population-based cross-sectional analysis of the seasons 2002/2003 and 2003/2004.
    Müller D; Wutzler P; Szucs TD
    Med Klin (Munich); 2005 Jan; 100(1):6-13. PubMed ID: 15654537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza vaccination in pregnancy.
    Yeager DP; Toy EC; Baker B
    Am J Perinatol; 1999; 16(6):283-6. PubMed ID: 10586981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influenza vaccination of nurses in an Italian pediatric hospital: effects on absenteeism and on costs, factors associated with vaccine uptake and analysis of personal motivations. A prospective cohort study].
    Festini F; Biermann KP; Neri S; Reali MF; de Martino M
    Assist Inferm Ric; 2007; 26(1):5-13. PubMed ID: 17489334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland.
    Mutsch M; Zhou W; Rhodes P; Bopp M; Chen RT; Linder T; Spyr C; Steffen R
    N Engl J Med; 2004 Feb; 350(9):896-903. PubMed ID: 14985487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; DeStefano F; Iskander JK; Haber P; Chen RT;
    Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):505-10. PubMed ID: 15317028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.
    Joseph A; Itskovitz-Cooper N; Samira S; Flasterstein O; Eliyahu H; Simberg D; Goldwaser I; Barenholz Y; Kedar E
    Vaccine; 2006 May; 24(18):3990-4006. PubMed ID: 16516356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.